Monday, April 28, 2025 4/28/2025

ENOBIA PHARMA INC

Group Recipients By:

Issue Date FY Summary


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Award Number	Award Title	Award Code	Budget Year	OPDIV	Action Date	Action Amount

Issue Date FY: 2013 ( Subtotal = $0 )
2013	2011	ENOBIA PHARMA INC	2901 RACHEL STREET EAST	MONTREAL		H1W4A		CAN	R01FD003745	Phase 2 Study of ENB-0040 for the Treatment of Hypophosphatasia	000	1	FDA	3/19/2013	$0
															Subtotal = $0

Issue Date FY: 2012 ( Subtotal = $0 )
2012	2011	ENOBIA PHARMA INC	2901 RACHEL STREET EAST	MONTREAL		H1W4A		CAN	R01FD003745	Phase 2 Study of ENB-0040 for the Treatment of Hypophosphatasia	000	1	FDA	11/22/2011	$0
2012	2011	ENOBIA PHARMA INC	2901 RACHEL STREET EAST	MONTREAL		H1W4A		CAN	R01FD003745	Phase 2 Study of ENB-0040 for the Treatment of Hypophosphatasia	002	1	FDA	9/25/2012	$0
2012	2011	ENOBIA PHARMA INC	2901 RACHEL STREET EAST	MONTREAL		H1W4A		CAN	R01FD003745	Phase 2 Study of ENB-0040 for the Treatment of Hypophosphatasia	001	1	FDA	5/24/2012	$0
															Subtotal = $0

Issue Date FY: 2011 ( Subtotal = $400,000 )
2011	2011	ENOBIA PHARMA INC	2901 RACHEL STREET EAST	MONTREAL		H1W4A		CAN	R01FD003745	Phase 2 Study of ENB-0040 for the Treatment of Hypophosphatasia	001	1	FDA	9/8/2011	$0
2011	2011	ENOBIA PHARMA INC	2901 RACHEL STREET EAST	MONTREAL				CAN	R01FD003745	Phase 2 Study of ENB-0040 for the Treatment of Hypophosphatasia	000	1	FDA	6/21/2011	$400,000
															Subtotal = $400,000

Grand Total All Awards = $400,000